# Fluorouracil-Uracil and Leucovorin in Treating Women With Metastatic Breast Cancer

> **NCT00005608** · PHASE2 · TERMINATED · sponsor: **Northwestern University**

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** leucovorin calcium
- **DRUG:** tegafur-uracil

## Key facts

- **NCT ID:** NCT00005608
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2000-02
- **Primary completion:** 2002-06
- **Final completion:** 2002-06
- **Target enrollment:** — (—)
- **Why stopped:** Drug was pulled from the market.
- **Last updated:** 2012-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005608, "Fluorouracil-Uracil and Leucovorin in Treating Women With Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00005608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*